Vaxcyte, Inc. (PCVX) has 19 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $3.4M. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 8, 2026 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | $1,029,500 | 17,056 | −4% | No | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 8, 2026 | GUGGENHIME ANDREW PRESIDENT AND CFO | $431,876 | 7,155 | −7% | No | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 8, 2026 | Dhaliwal Harpreet S. Chief Technical Ops Officer | $461,814 | 7,651 | −10% | No | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 8, 2026 | Cowan Elvia SVP, Finance & CAO | $80,098 | 1,327 | −5% | No | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 4, 2026 | Wassil Jim EVP, Chief Scientific Ofc, COO | −$493,368 | 8,174 | −5% | No | |
|
|
||||||
Showing the 5 most recent of 19 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free